Flaherty L - Search Results

1

Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.

Vaishampayan U, Flaherty L, Du W, Hussain M. Vaishampayan U, et al. Among authors: flaherty l. Cancer. 2001 Aug 1;92(3):519-23. doi: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-#. Cancer. 2001. PMID: 11505395 Clinical Trial.

2

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Poplin EA, Corbett T, Flaherty L, Tarasoff P, Redman BG, Valdivieso M, Baker L. Poplin EA, et al. Among authors: flaherty l. Invest New Drugs. 1992 Aug;10(3):165-70. doi: 10.1007/BF00877241. Invest New Drugs. 1992. PMID: 1428726 Clinical Trial.

3

Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial.

Flaherty LE, Liu PY, Fletcher WS, Goodwin JW, Balcerzak SP, Daniels D, Stephens RL, Sondak VK. Flaherty LE, et al. J Natl Cancer Inst. 1992 Jun 3;84(11):893-4. doi: 10.1093/jnci/84.11.893. J Natl Cancer Inst. 1992. PMID: 1593656 Clinical Trial. No abstract available.

4

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

5

Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Martino S, et al. Among authors: flaherty l. Breast Cancer Res Treat. 1990 Dec;17(2):139-43. doi: 10.1007/BF01806294. Breast Cancer Res Treat. 1990. PMID: 2096991 Clinical Trial.

6

A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer.

Redman BG, Flaherty L, Chou TH, al-Katib A, Kraut M, Martino S, Chen B, Kaplan J, Valdivieso M. Redman BG, et al. Among authors: flaherty l. J Clin Oncol. 1990 Jul;8(7):1269-76. doi: 10.1200/JCO.1990.8.7.1269. J Clin Oncol. 1990. PMID: 2113571

7

Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.

Chabot GG, Flaherty LE, Valdivieso M, Baker LH. Chabot GG, et al. Among authors: flaherty le. Cancer Chemother Pharmacol. 1990;27(2):157-60. doi: 10.1007/BF00689102. Cancer Chemother Pharmacol. 1990. PMID: 2249333

8

A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.

Flaherty LE, Redman BG, Chabot GG, Martino S, Gualdoni SM, Heilbrun LK, Valdivieso M, Bradley EC. Flaherty LE, et al. Cancer. 1990 Jun 1;65(11):2471-7. doi: 10.1002/1097-0142(19900601)65:11<2471::aid-cncr2820651113>3.0.co;2-f. Cancer. 1990. PMID: 2337862

9

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.

Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE. Pienta KJ, et al. Among authors: flaherty le. J Clin Oncol. 1994 Oct;12(10):2005-12. doi: 10.1200/JCO.1994.12.10.2005. J Clin Oncol. 1994. PMID: 7523606 Clinical Trial.

10

Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma.

Redman BG, Abubakr Y, Chou T, Esper P, Flaherty LE. Redman BG, et al. Among authors: flaherty le. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):211-5. doi: 10.1097/00002371-199410000-00005. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834120 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters